Similar articles

• The metabolism of Tay-Sachs ganglioside: catabolic studies with lysosomal enzymes from normal and Tay-Sachs brain tissue.

  Tallman JF, Johnson WG, Brady RO. Tallman JF, et al. J Clin Invest. 1972 Sep;51(9):2339-45. doi: 10.1172/JCI107045. J Clin Invest. 1972. PMID: 4639018 Free PMC article.
• Preparation of radioactive Tay-Sachs ganglioside labeled in the sialic acid moiety.

  Kolodny EH, Brady RO, Quirk JM, Kanfer JN. Kolodny EH, et al. J Lipid Res. 1970 Mar;11(2):144-9. J Lipid Res. 1970. PMID: 5418476
• The preparation of Tay-Sachs ganglioside specifically labeled in either the N-acetylneuraminosyl or N-acetylgalactosaminyl portion of the molecule.

  Tallman JF, Kolodny EH, Brady RO. Tallman JF, et al. Methods Enzymol. 1975;35:541-8. doi: 10.1016/0076-6879(75)35182-3. Methods Enzymol. 1975. PMID: 1121293 No abstract available.
• The enzymology of Tay-Sachs disease and its variant forms.

  Tallman JF. Tallman JF. UCLA Forum Med Sci. 1975;(18):479-99. doi: 10.1016/b978-0-12-139050-1.50035-5. UCLA Forum Med Sci. 1975. PMID: 812231 Review. No abstract available.
• Some aspects of the cellular biochemistry of lysosomal and related glycosidases.

  Touster O. Touster O. Mol Cell Biochem. 1973 Dec 15;2(2):169-77. doi: 10.1007/BF01795471. Mol Cell Biochem. 1973. PMID: 4594433 Review. No abstract available.